Clinical trial
A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In…
NCT00463320 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00463320 |
|---|---|
| Title | A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects. |
| Official title | A Placebo-controlled, Randomized, Dose Rising Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Ocular Doses of Pazopanib in Healthy Adult and Elderly Subjects. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Age-related Macular Degeneration |
| Intervention type | Drug |
| Interventions | Pazopanib eye drops and Allergen Refresh Plus eye drops |
| Enrollment | 29 |
| Start date | Mar 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 20, 2007 |
| Last update posted | Mar 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: